SEARCH

SEARCH BY CITATION

References

  • 1
    Peeters A, Mamun AAF, Willekens F, Bonneux L, for NEDCOM. A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J 2002; 23: 45866.
  • 2
    Yusuf S, Flather M, Pogue J, for the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry Investigators. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998; 352: 50714.
  • 3
    Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284: 29016.
  • 4
    Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology 1997; 48: 8915.
  • 5
    Chiu JH, Topol EJ, Whitlow PL, Hsu AP, Tuzcu EM, Franco I, Moliterno DJ. Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization. Am J Cardiol 2003; 92: 5823.
  • 6
    Cotter G, Cannon CP, McCabe CH, Michowitz Y, Kaluski E, Charlesworth A, Milo O, Bentley J, Blatt A, Krakover R, Zimlichman R, Reisin L, Marmor A, Lewis B, Vered Z, Caspi A, Braunwald E, for the OPUS-TIMI 16 Investigators. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiman in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction. Am Heart J 2003; 145: 6227.
  • 7
    Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh BJ, for the CASS Investigators. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. J Am Coll Cardiol 1994; 23: 10915.
  • 8
    Sutton-Tyrrell K, Rihal C, Sellers MA, Burek K, Trudel J, Roubin G, Brooks MM, Grogen M, Sopko G, Keller N, Jandorà R, for the BARI investigators. Long-term prognostic value of clinically evident non coronary vascular disease in patients undergoing coronary revascularization in the By-pass Angioplasty Revascularization investigation (BARI). Am J Cardiol 1998; 81: 37581.
  • 9
    Cupples LA, Gagnon DR, Wong ND, Ostfeld AM, Kannel WB. Pre-existing cardiovascular conditions and long-term prognosis after initial myocardial infarction: the Framingham study. Am Heart J 1993; 125: 86372.
  • 10
    Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness and treatment in Primary Case. JAMA 2001; 286: 131724.
  • 11
    McDermott MM. Ankle brachial index as a predictor of outcomes in peripheral arterial disease. J Lab Clin Med 1999; 133: 3340.
  • 12
    Criqui MH, Langer MR, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 3816.
  • 13
    Leng GC, Lee AJ, Fowkes FGR, Witheman M, Dunbar J, Housley E, Ruckley CY. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 117281.
  • 14
    Tonelli C, Finzi G, Catamo A, Silvestrini C, Squeri M, Mombelloni A, Ponari O. Prevalence and prognostic value of peripheral arterial disease in stroke patients. Int Angiol 1993; 12: 3423.
  • 15
    Papamichael CM, Lekakis JP, Stamatelopulos KS, Papaioannou TG, Alevizaki MK, Cimponeriu AT, Kanakakis JE, Papapanagiotou A, Kalafoutis AT, Stamatelopoulos JF. Ankle brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 2000; 86: 6158.
  • 16
    Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1996; 1: 6571.
  • 17
    McDermott MM, Criqui MH, Liu K, Guralnik JM, Greenland P, Martin GJ, Pearce W. Lower ankle/brachial index as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures and association with leg functioning in peripheral arterial disease. J Vasc Surg 2000; 232: 116471.
  • 18
    Kaiser W, Kester AD, Stoffers HE, Kitslaar PJ, Knottnerus JA. The influence of experience of reproducibility of the ankle brachial systolic pressure ratio in peripheral arterial occlusive disease. Eur J Endovasc Surg 1999; 18: 259.
  • 19
    Nomenclature and Criteria for Diagnosis of Ischaemic Heart Disease. Report of the Joint International Society and Federation of cardiology/World Health Organization task force on standardization on clinical nomenclature. Circulation 1979; 59: 6079.
  • 20
    Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh 3rd EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 3541.
  • 21
    Kornitzer M, Dramaix M, Sobolski J, Degre S, De Backer G. Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology 1995; 46: 249.
  • 22
    Newman AB, Shemonski L, Monolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D. Ankle–arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health Study. Arterioscl Thromb Vasc Biol 1999; 19: 53845.
  • 23
    Lee AJ, Price JF, Russel MJ, Smith FB, Van Wijk MCW, Fowkes FGR. Improved prediction of fatal myocardial infarction using the ankle brachial index in addition to conventional risk factors. The Edinburgh Artery study. Circulation 2004; 110: 307580.
  • 24
    Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, Yusuf S, HOPE study investigators. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 2004; 25: 1724.
  • 25
    Kannel WB, Mc Gee DL. Update on some epidemiological features of intermittent claudication: the Framingham study. J Am Geriatr Soc 1985; 22: 138.
  • 26
    Tsai AW, Folsom AR, Rosamond WD, Jones DW. Ankle–brachial index and 7-year ischemic stroke incidence. The ARIC Study. Stroke 2001; 32: 17214.
  • 27
    Abbott RD, Rodriguez BL, Petrovitch H, Yano K, Masaki KH, Ross GW, Curb DJ. Ankle–brachial blood pressure in elderly men and the risk of stroke: the Honolulu Heart Program. J Clin Epidemiol 2001; 54: 9738.
  • 28
    Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000; 31: 20806.
  • 29
    Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse 3rd JR, Friedman L, Fuster V, Herrington DM, Kuller LH, Ridker PM, Roberts WC, Stanford W, Stone N, Swan HJ, Taubert KA, Wexler L. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000; 101: E1622.
  • 30
    Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V. C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 138797
  • 31
    Di Napoli M, Di Gianfilippo G, Sollecito A, Bocola V. C-reactive protein and outcome after first-ever ischemic stroke. Stroke 2000; 31: 2389.
  • 32
    Kinjo K, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, Imai K, Nanto S, Naka M, Matsumura Y, Takeda H, Hori M, Osaka Acute Coronary Insufficiency Study (OACIS) Group. Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am J Cardiol 2003; 91: 9315.
  • 33
    Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB, Intermountain Heart Collaborative (IHC) Study Group. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 2002; 89: 1459.
  • 34
    Kannel WB, Skinner Jr JJ, Schwartz MJ, Shurtleff D. Intermittent claudication: incidence in the Framingham Study. Circulation 1970; 41: 87583.
  • 35
    Stoffers HEJH, Kester ADM, Kaiser V, Rinkens PELM, Kitslaar PJEHM, Knottnerus AJ. The diagnostic value of the measurement of the ankle–brachial systolic pressure index in primary health care. J Clin Epidemiol 1996; 49: 14015.
  • 36
    Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, Pittrow D, Von Stritzky B, Tepohl G, Trampisch HJ. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172: 95105.
  • 37
    Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon 3rd RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith Jr SC, Taubert K, Tracy RP, Vinicor F, Centers for Disease Control and Prevention, American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499511.
  • 38
    McDermott MM, Green D, Greenland P, Liu K, Criqui MH, Chan C, Guralnik JM, Pearce WH, Ridker PM, Taylor L, Rifai N, Schneider JR. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003; 92: 1949.
  • 39
    Yusuf S. Commentary – two decades of progress in preventing vascular disease. Lancet 2002; 360: 23.
  • 40
    Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 38393.
  • 41
    Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB, Pasternak RC, Smith Jr SC, Stone NJ, National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 22739.